BioSpace News Archive

An obscure sliver of RNA with a grim-sounding name is unexpectedly taking center stage as a linchpin in transforming pre-leukemic cells into full-blown leukemia. Apexian Pharmaceuticals’ latest studies in collaboration with Indiana University’s Simon Cancer Center investigator Dr. Reuben Kapur show promise for halting that transformation.

Aurinia Pharmaceuticals Inc., announced its Chairman and Chief Executive Officer, Richard M. Glickman, will present a company overview at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Thursday, January 10, 2019 at 10:00am PST, 1pm EST

Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing novel therapies for urologic conditions, today announced chief executive officer Keith A. Katkin is scheduled to present a corporate overview at the J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019 at 8:00 a.m. PT in San Francisco.

ARS Pharmaceuticals, Inc., a pharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions potentially leading to anaphylaxis, has raised $20 million in Series C financing led by Deerfield Management.

X-Chem, Inc., a privately held biotechnology company focused on applying its industry-leading DNA-encoded (DEX™) library drug discovery engine to the generation of novel small molecule therapeutics, today announced the signing of a broad strategic drug discovery collaboration with Bristol-Myers Squibb. T

DisposeRx Inc. (http://www.disposerx.com) today announced that senior retail healthcare executive, George Riedl, will serve as a strategic advisor for the company as it continues to expand its relationships with health plans, payors, pharmaceutical manufacturers, pharmacy benefit managers and pharmacies nationwide.

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care products and services to office-based dental, animal health, and medical practitioners, announced today that the Company will present at the 2019 J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019, at 2:30 p.m. Pacific time/5:30 p.m. Eastern time at the Westin St. Francis Hotel in San Francisco.

Mevion Medical Systems announced today that Chief Executive Officer, Tina Yu, Ph.D., will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 09, 2019 at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time at the Westin St. Francis Hotel in San Francisco, California.

InnovHeart s.r.l., a developer of novel transcatheter mitral valve replacement (TMVR) systems for the treatment of cardiac disease, is very pleased to announce the appointment of experienced medical device executive Jason Bottiglieri to the role of Chief Executive Officer of the company and executive member of the Board of Directors.

Shatterproof Rating System will offer individuals a reliable source of information when making decisions about treatment options